STOCK TITAN

10,000-share Rule 144 sale by RAPP (NASDAQ: RAPP) lists $278,400 value

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

RAPP submitted a Rule 144 notice listing a proposed sale of 10,000 shares of Common stock. The filing shows a value of $278,400.00 and references Cheryl Gault with an address on the filing. Dates shown include 09/05/2024 and 03/30/2026.

Positive

  • None.

Negative

  • None.

Insights

Routine Rule 144 notice for an insider resale of 10,000 common shares.

The filing lists a proposed resale of $278,400.00 worth of 10,000 common shares under Rule 144 and names Cheryl Gault in the signature/remarks line. The document appears to be an administrative resale notice rather than a corporate action.

The filing includes dates 09/05/2024 and 03/30/2026; timing and exact sale mechanics are not detailed in the excerpt. Subsequent SEC or broker reports would show execution status.

Shares to be sold 10,000 shares Securities To Be Sold line dated 09/05/2024
Reported value $278,400.00 Securities Information value field
Reference number 47,792,943 Securities Information line (03/30/2026)
Additional amount shown 58,265.02 Line with Cheryl Gault entry dated 03/05/2026
Rule 144 regulatory
"Securities To Be Sold / 09/05/2024 / Founders Shares"
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
Founders Shares financial
"Founders Shares | Issuer | 10000 | 09/05/2024"
Founders shares are a special block of a company’s stock originally given to the people who started the business; they often carry extra voting power or favorable terms compared with regular shares. For investors, these shares matter because they concentrate control and influence how future funding, ownership dilution, and decision-making will play out—think of founders shares as the steering wheel that can steer a company’s direction even as more passengers (investors) climb aboard.
Securities To Be Sold regulatory
"Common | Morgan Stanley Smith Barney LLC Executive Financial Services"

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does RAPP's Form 144 disclose about the sale?

It discloses a proposed sale of 10,000 shares of common stock. The filing lists a value of $278,400.00 and names Cheryl Gault with associated filing dates and address details for the seller.

Who is listed as the reporting person on the RAPP Form 144?

The filing lists Cheryl Gault with an address at 99 High Street, Suite 2100, Boston. The line appears in the remarks/signature area and is tied to a common-stock sale entry on the form.

How many shares and what value are shown on the RAPP Form 144?

The form shows 10,000 shares and a monetary figure of $278,400.00. These figures are presented on the securities and value lines within the excerpted content.

Does the Form 144 indicate when the sale will occur?

The excerpt displays dates including 09/05/2024 and 03/30/2026, but it does not state a specific execution date or trade method for the sale. Further filings would be needed for confirmed execution details.
Rapport Therapeutics Inc

NASDAQ:RAPP

View RAPP Stock Overview

RAPP Rankings

RAPP Latest News

RAPP Latest SEC Filings

RAPP Stock Data

1.32B
44.92M
Biotechnology
Pharmaceutical Preparations
Link
United States
BOSTON